Home » Newsletters » BioWorld Science

BioWorld Science

April 22, 2022

View Archived Issues

MRT-2359 shows promise for Myc-driven solid tumors

M-1774 demonstrates potent antitumor activity both as monotherapy and in combination

Post viral infection, resting T-cell subtypes cooperate to drive neuroinflammation

Incyte discloses new GTPase KRAS mutant inhibitors

Cadila Healthcare patents viral nsp3 inhibitors

Asahi Kasei Pharma and Vernalis Group present new IRAK inhibitors

Janssen synthesizes new DHODH inhibitors

Sunshine Lake Pharma patents new GNRHR antagonists

JNJ-78306358, a novel bispecific antibody with HLA-G expression-dependent antitumor activity

Cocrystal Pharma's 3CL protease inhibitors to be studied by NIAID for COVID-19

Discovery of novel orally bioavailable CREB inhibitor

Codexis and seqWell partner to accelerate commercialization of genomics workflow solutions

Novel PAD4 inhibitor JBI-1044 shows strong potency for cancer treatment

CureVac reports preclinical data on bivalent second-generation COVID-19 vaccine

n-Lorem receives funding to support ASO discovery for nano-rare neurodevelopmental diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...